Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2010

01-10-2010 | Breast Oncology

Impact of US Surveillance on Detection of Clinically Occult Locoregional Recurrence after Mastectomy for Breast Cancer

Authors: Hye Jung Kim, Jin Young Kwak, MD, Joo Wan Choi, Ji Hea Bae, Kyung Min Shin, Hui Joong Lee, MD, Gab Chul Kim, MD, Jin Hyang Jung, MD, Ji Young Park, MD

Published in: Annals of Surgical Oncology | Issue 10/2010

Login to get access

Abstract

Background

This study investigated the efficacy of locoregional ultrasonography (LRUS) for the detection of recurrence in asymptomatic patients who underwent mastectomy and the impact of LRUS on prognosis.

Materials and Methods

A total of 1796 LRUSs were performed in 874 asymptomatic patients who showed no clinical evidence of recurrence after mastectomy. Ultrasonography (US) results were considered positive when US detected any masses at the mastectomy bed or suspicious regional lymph nodes. The final diagnosis of each patient was based on cytopathology results or data collected during the follow-up. The median follow-up was 37 months. We evaluated diagnostic performance of LRUS at the detection of locoregional recurrence (LRR) and compared overall survival of asymptomatic patients with recurrences to that of symptomatic patients with recurrences.

Results

Of 874 asymptomatic patients, 57 patients (6.5%) had suspicious LRR on LRUS. The positive predictive value (PPV) of LRUS was 26.3% with 15 recurrences diagnosed in 15 patients (cancer detection rate, 1.7% per patient and 0.8% per examination). Asymptomatic patients with recurrences had better survival compared with symptomatic patients with recurrences (P = .034).

Conclusions

LRUS during breast US after mastectomy for breast cancer was helpful for the early detection of recurrence and may lead to a better prognosis for patients.
Literature
1.
Solin LJ, Harris EER, Orel SG, et al. Local-regional recurrence after breast-conservation treatment or mastectomy. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
2.
Lu WL, Jansen L, Post WJ, et al. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403–12.CrossRefPubMed
3.
Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg. 2006;203:469–74.CrossRefPubMed
4.
Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev. 2001;27:67–82.CrossRefPubMed
5.
Hiramanek N. Breast cancer recurrence: follow up after treatment for primary breast cancer. Postgrad Med J. 2004;80:172–6.CrossRefPubMed
6.
Kim SM, Park JM. Normal and abnormal US findings at the mastectomy site. Radiographics. 2004;24:357–65.CrossRefPubMed
7.
Moon HJ, Kim MJ, Kim EK, et al. US surveillance of regional lymph node recurrence after breast cancer surgery. Radiology. 2009;252:673–81.CrossRefPubMed
8.
Shin JH, Han BK, Choe YH, et al. Ultrasonographic detection of occult cancer in patients after surgical therapy for breast cancer. J Ultrasound Med. 2005;24:643–9.PubMed
9.
Fajardo LL, Roberts CC, Hunt KR. Mammographic surveillance of breast cancer patients: should the mastectomy site be imaged? AJR Am J Roentgenol. 1993;161:953–5.PubMed
10.
Propeck PA, Scanlan KA. Utility of axillary views in postmastectomy patients. Radiology. 1993;187:769–71.PubMed
11.
Yilmaz MH, Esen G, Ayarcan Y, et al. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy. Diagn Interv Radiol. 2007;13:13–8.PubMed
12.
Stavros AT. Sonographic evaluation of the iatrogenically altered breast. In: Stavros AT, editor. Breast Ultrasound, 1st ed. Philadelphia, Lippincott Williams & Wilkinsl; 2004.
13.
Brenner RJ, Pfaff JM. Mammographic changes after excisional breast biopsy for benign disease. AJR Am J Roentgenol. 1996;167:1047–52.PubMed
14.
Ahuja AT, Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol. 2005;184:1691–9.PubMed
15.
Esen G, Gurses B, Yilmaz MH, et al. Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol. 2005;15:1215–23.CrossRefPubMed
16.
Feu J, Tresserra F, Fabregas R, et al. Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. Radiology. 1997;205:831–5.PubMed
17.
Yang WT, Chang J, Metreweli C. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology. 2000;215:568–73.PubMed
18.
Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology. 1992;183:215–20.PubMed
19.
Abe H, Schmidt RA, Kulkarni K, et al. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy–clinical experience in 100 patients. Radiology. 2009;250:41–9.CrossRefPubMed
20.
Orel SG, Fowble BL, Solin LJ, et al. Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: prognostic significance of detection method. Radiology. 1993;188:189–94.PubMed
21.
Rissanen TJ, Makarainen HP, Mattila SI, et al. Breast cancer recurrence after mastectomy: diagnosis with mammography and US. Radiology. 1993;188:463–7.PubMed
22.
The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA. 1994;271:1587–92.
23.
Rosselli Del Turco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994;271:1593–7.CrossRefPubMed
24.
Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol, Biol, Phys. 1985;11:137–45.
25.
Recht A, Schnitt SJ, Connolly JL, et al. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol, Biol, Phys. 1989;16:3–9.
26.
Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol, Biol, Phys. 1990;19:833–42.
27.
Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol, Biol, Phys. 1990;18:87–93.
28.
Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol, Biol, Phys. 1991;21:293–8.
29.
Dalberg K, Mattsson A, Sandelin K, et al. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998;49:69–78.CrossRefPubMed
30.
de Bock GH, Bonnema J, van der Hage J, et al. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol. 2004;22:4010–8.CrossRefPubMed
31.
Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.CrossRefPubMed
32.
Montgomery DA, Krupa K, Cooke TG. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Brit J Cancer. 2007;97:1632–41.CrossRefPubMed
33.
Mellink WA, Holland R, Hendriks JH, et al. The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer. 1991;67:1844–8.CrossRefPubMed
34.
Grunfeld E, Noorani H, McGahan L, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11:228–35.CrossRefPubMed
35.
Edeiken BS, Fornage BD, Bedi DG, et al. Recurrence in autogenous myocutaneous flap reconstruction after mastectomy for primary breast cancer: US diagnosis. Radiology. 2003;227:542–8.CrossRefPubMed
36.
Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–27.PubMed
37.
Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–700.PubMed
38.
Andry G, Suciu S, Vico P, et al. Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol. 1989;15:476–85.PubMed
39.
Chaudary MA, Tong D, Millis R, et al. Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence. Eur J Surg Oncol. 1997;23:348–53.CrossRefPubMed
40.
Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol. 2003;21:1205–13.CrossRefPubMed
41.
Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol, Biol, Phys. 1997;37:853–63.
42.
Bedwinek JM, Lee J, Fineberg B, et al. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer. 1981;47:2232–5.CrossRefPubMed
43.
Magno L, Bignardi M, Micheletti E, et al. Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer. Cancer. 1987;60:240–4.CrossRefPubMed
44.
Janni W, Dimpfl T, Braun S, et al. Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival. Int J Radiat Oncol, Biol, Phys. 2000;48:967–75.CrossRef
45.
Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol. 1993;32:641–6.CrossRefPubMed
46.
van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999;35:32–8.CrossRefPubMed
47.
Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ. 1998;158:S65–70.
48.
Elder EE, Kennedy CW, Gluch L, et al. Patterns of breast cancer relapse. Eur J Surg Oncol. 2006;32:922–7.CrossRefPubMed
Metadata
Title
Impact of US Surveillance on Detection of Clinically Occult Locoregional Recurrence after Mastectomy for Breast Cancer
Authors
Hye Jung Kim
Jin Young Kwak, MD
Joo Wan Choi
Ji Hea Bae
Kyung Min Shin
Hui Joong Lee, MD
Gab Chul Kim, MD
Jin Hyang Jung, MD
Ji Young Park, MD
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1087-z

Other articles of this Issue 10/2010

Annals of Surgical Oncology 10/2010 Go to the issue

Melanomas

Utility of Preoperative 18F-FDG PET/CT and Brain MRI in Melanoma Patients with Palpable Lymph Node Metastases

Gastrointestinal Oncology

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

Gastrointestinal Oncology

Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection

Hepatobiliary Tumors

Predictors of Extrahepatic Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma

Healthcare Policy and Outcomes

Trends in Contralateral Prophylactic Mastectomy for Unilateral Cancer: A Report From the National Cancer Data Base, 1998–2007

Breast Oncology

Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach